Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms

References

• Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–799.
   PubMed Web of Science ®Google Scholar
• Maitra A, Fukushima N, Takaori K, et al. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12:81–91.
   PubMed Web of Science ®Google Scholar
• Tanaka M. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus. Digestion. 2014;90:265–272.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197.
   PubMed Web of Science ®Google Scholar
• Fritz S, Klauss M, Bergmann F, et al. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk. Ann Surg. 2014;260:848–855.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Nishihara K, Niina Y, et al. Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012 a retrospective review. Surg Today. 2016;46:1045–1052.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ohtsuka T, Fujimoto T, et al. Revised point of the international consensus guidelines 2012 for the management of IPMN of the pancreas. Kan Tan Sui. 2014;69:1201–1206.
   Google Scholar
• Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumor site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104:726–734.
   PubMed Web of Science ®Google Scholar
• Kasymjanova G, MacDonald N, Agulnik JS, et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol. 2010;17:52–58.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Kimura Y, Ishida M, et al. Correlation of pre-operative nutritional condition with postoperative complications in surgical treatment for esophageal carcinoma. Eur J Surg Oncol. 2002;28:396–400.
   PubMed Web of Science ®Google Scholar
• Smith RA, Bosonnet L, Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic adenocarcinoma. Am J Surg. 2009;197:466–472.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhang W, Feng LJ. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS One. 2014;9:e111906.
   PubMed Web of Science ®Google Scholar
• Walsh SR, Cook EJ, Goulder F, et al. Neutrophil–lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–184.
   PubMed Web of Science ®Google Scholar
• Asari S, Matsumoto I, Toyama H, et al. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Surg Today. 2016;46:583–592.
   PubMed Web of Science ®Google Scholar
• Koshita S, Fujita N, Noda Y, et al. Invasive carcinoma derived from “flat type” branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography. J Hepatobiliary Pancreat Sci. 2015;22:301–309.
   PubMed Web of Science ®Google Scholar
• Kobayashi G, Fujita N, Noda Y, et al. Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas. J Med Ultrasonics. 2008;35:85–96.
   PubMed Web of Science ®Google Scholar
• Adsay NV, Fukushima N, Furukawa T, et al. Intraductal neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010. p. 304–313
   Google Scholar
• Goh BK, Thng CH, Tan DM, et al. Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients. Am J Surg. 2014;208:202–209.
   PubMed Web of Science ®Google Scholar
• Seo N, Byun JH, Kim JH, et al. Validation of the 2012 international consensus guidelines using computed tomography and magnetic resonance imaging: brunch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2016;263:557–564.
   PubMed Web of Science ®Google Scholar
• Nguyen AH, Toste PA, Farrell JJ, et al. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer. J Gastrointest Surg. 2015;19:258–265.
   PubMed Web of Science ®Google Scholar
• Shimoda M, Kubota K, Katoh M, et al. Effect of billroth II or Roux-en-Y reconstruction for the gastrojejunostomy on delayed gastric emptying after pancreaticoduodenectomy: a randomized controlled study. Ann Surg. 2013;257:938–942.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ohtsuka T, Kimura H, et al. Braun enteroenterostomy reduces delayed gastric emptying after pylorus-preserving pancreatoduodenectomy: a retrospective review. Am J Surg. 2015;209:369–377.
   PubMed Web of Science ®Google Scholar
• Hamada S, Masamune A, Shimosegawa T. Inflammation and pancreatic cancer: disease promoter and new therapeutic target. J Gastroenterol. 2014;49:605–617.
   PubMed Web of Science ®Google Scholar
• Sadot E, Basturk O, Klimstra DS, et al. Tumor-associated neutrophils and malignant progression in intraductal papillary mucinous neoplasms: an opportunity for identification of high-risk disease. Ann Surg. 2015;262:1102–1107.
   PubMed Web of Science ®Google Scholar
• Inman KS, Francis AA, Murray NR. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol. 2014;20:11160–11181.
   PubMed Web of Science ®Google Scholar
• Gemenetzis G, Bagante F, Griffin JF, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266:339–345.
   PubMed Web of Science ®Google Scholar
• Arima K, Okabe H, Hashimoto D, et al. The neutrophil-to-lymphocyte ratio predicts malignant potential in intraductal papillary mucinous neoplasms. J Gastrointest Surg. 2015;19:2171–2177.
   PubMed Web of Science ®Google Scholar
• Goh BK, Tan DM, Chan CY, et al. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms? J Surg Oncol. 2015;112:366–371.
   PubMed Web of Science ®Google Scholar